VLT-RT (Retatrutide) is glp-1 / gip / glucagon receptor agonist. Triple-receptor (GLP-1/GIP/glucagon) agonist for incretin-pathway research. Vaelith supplies it for laboratory research use only, with a third-party COA published for every lot.
Lot VLT-R20-001 was independently tested by Kovera Labs at 99.604% HPLC purity on 2026-08-11. View the full certificate →
VLT-RT (Retatrutide) is glp-1 / gip / glucagon receptor agonist. Triple-receptor (GLP-1/GIP/glucagon) agonist for incretin-pathway research.
Yes. Every Vaelith Retatrutide lot is independently tested by a third-party laboratory for HPLC purity and mass-spectrometry identity, and the certificate is published publicly. The latest lot measured 99.604% purity, tested by Kovera Labs.
Retatrutide has a molecular weight of 4731.42 g/mol and a molecular formula of C221H342N46O68 (CAS 2381089-83-2).
Yes, Vaelith ships from the United States. Retatrutide is supplied strictly for laboratory research use only, not for human or veterinary use.